These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 20682656

  • 1. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
    Levy R, Grafi-Cohen M, Kraiem Z, Kloog Y.
    Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656
    [Abstract] [Full Text] [Related]

  • 2. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Charette N, De Saeger C, Lannoy V, Horsmans Y, Leclercq I, Stärkel P.
    Mol Cancer; 2010 Sep 22; 9():256. PubMed ID: 20860815
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of malignant thyroid carcinoma cell proliferation by Ras and galectin-3 inhibitors.
    Menachem A, Bodner O, Pastor J, Raz A, Kloog Y.
    Cell Death Discov; 2015 Sep 22; 1():15047. PubMed ID: 27551476
    [Abstract] [Full Text] [Related]

  • 4. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
    Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y.
    Clin Cancer Res; 2005 Jun 15; 11(12):4321-30. PubMed ID: 15958613
    [Abstract] [Full Text] [Related]

  • 5. Ras inhibits endoplasmic reticulum stress in human cancer cells with amplified Myc.
    Yaari-Stark S, Shaked M, Nevo-Caspi Y, Jacob-Hircsh J, Shamir R, Rechavi G, Kloog Y.
    Int J Cancer; 2010 May 15; 126(10):2268-81. PubMed ID: 19998334
    [Abstract] [Full Text] [Related]

  • 6. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B, Starinsky S, Friedman E, Stein R, Kloog Y.
    Clin Cancer Res; 2006 Sep 15; 12(18):5533-42. PubMed ID: 17000690
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The inhibition of human mesangial cell proliferation by S-trans, trans-farnesylthiosalicylic acid.
    Khwaja A, Sharpe CC, Noor M, Kloog Y, Hendry BM.
    Kidney Int; 2005 Aug 15; 68(2):474-86. PubMed ID: 16014024
    [Abstract] [Full Text] [Related]

  • 11. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
    Piscazzi A, Costantino E, Maddalena F, Natalicchio MI, Gerardi AM, Antonetti R, Cignarelli M, Landriscina M.
    J Clin Endocrinol Metab; 2012 Jun 15; 97(6):E898-906. PubMed ID: 22442268
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L, Haklai R, Bauer V, Heiss A, Kloog Y.
    J Med Chem; 2009 Jan 08; 52(1):197-205. PubMed ID: 19072665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
    Aizman E, Mor A, Levy A, George J, Kloog Y.
    Oncotarget; 2012 Feb 08; 3(2):144-57. PubMed ID: 22323550
    [Abstract] [Full Text] [Related]

  • 17. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B.
    Mol Med; 2000 Aug 08; 6(8):693-704. PubMed ID: 11055588
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.